Keith Norris to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications Keith Norris has written about Randomized Controlled Trials as Topic.
Connection Strength
0.227
-
Vaziri ND, Norris KC. Reasons for the lack of salutary effects of cholesterol-lowering interventions in end-stage renal disease populations. Blood Purif. 2013; 35(1-3):31-6.
Score: 0.105
-
Norris K, Vaughn C. The role of renin-angiotensin-aldosterone system inhibition in chronic kidney disease. Expert Rev Cardiovasc Ther. 2003 May; 1(1):51-63.
Score: 0.053
-
Kusek JW, Lee JY, Charleston J, Faulkner M, Levell B, Milligan S, Norris K. Participant satisfaction in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Control Clin Trials. 1996 Aug; 17(4 Suppl):47S-54S.
Score: 0.033
-
Appel LJ, Middleton J, Miller ER, Lipkowitz M, Norris K, Agodoa LY, Bakris G, Douglas JG, Charleston J, Gassman J, Greene T, Jamerson K, Kusek JW, Lewis JA, Phillips RA, Rostand SG, Wright JT. The rationale and design of the AASK cohort study. J Am Soc Nephrol. 2003 Jul; 14(7 Suppl 2):S166-72.
Score: 0.013
-
Sarkisian CA, Brown AF, Norris KC, Wintz RL, Mangione CM. A systematic review of diabetes self-care interventions for older, African American, or Latino adults. Diabetes Educ. 2003 May-Jun; 29(3):467-79.
Score: 0.013
-
Whelton PK, Lee JY, Kusek JW, Charleston J, DeBruge J, Douglas M, Faulkner M, Greene PG, Jones CA, Kiefer S, Kirk KA, Levell B, Norris K, Powers SN, Retta TM, Smith DE, Ward H. Recruitment experience in the African American Study of Kidney Disease and Hypertension (AASK) Pilot Study. Control Clin Trials. 1996 Aug; 17(4 Suppl):17S-33S.
Score: 0.008